170 related articles for article (PubMed ID: 35545106)
1. Inter-Reader Variability Using PI-RADS v2 Versus PI-RADS v2.1: Most New Disagreement Stems from Scores 1 and 2.
Beetz NL; Haas M; Baur A; Konietschke F; Roy A; Hamm CA; Rudolph MM; Shnayien S; Hamm B; Cash H; Asbach P; Penzkofer T
Rofo; 2022 Aug; 194(8):852-861. PubMed ID: 35545106
[TBL] [Abstract][Full Text] [Related]
2. PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
Bhayana R; O'Shea A; Anderson MA; Bradley WR; Gottumukkala RV; Mojtahed A; Pierce TT; Harisinghani M
AJR Am J Roentgenol; 2021 Jul; 217(1):141-151. PubMed ID: 32903060
[No Abstract] [Full Text] [Related]
3. Head-to-head comparison of PI-RADS v2 and PI-RADS v1.
Polanec S; Helbich TH; Bickel H; Pinker-Domenig K; Georg D; Shariat SF; Aulitzky W; Susani M; Baltzer PA
Eur J Radiol; 2016 Jun; 85(6):1125-31. PubMed ID: 27161062
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
Wei CG; Zhang YY; Pan P; Chen T; Yu HC; Dai GC; Tu J; Yang S; Zhao WL; Shen JK
AJR Am J Roentgenol; 2021 May; 216(5):1247-1256. PubMed ID: 32755220
[No Abstract] [Full Text] [Related]
5. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate.
Liu Y; Wang S; Xu G; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
J Magn Reson Imaging; 2023 Sep; 58(3):709-717. PubMed ID: 36773016
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Prostate Imaging and Reporting Data System V2.0 and V2.1 for Evaluation of Transition Zone Lesions: A 5-Reader 202-Patient Analysis.
Kim N; Kim S; Prabhu V; Shanbhogue K; Smereka P; Tong A; Anthopolos R; Taneja SS; Rosenkrantz AB
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):523-529. PubMed ID: 35405714
[TBL] [Abstract][Full Text] [Related]
8. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
[TBL] [Abstract][Full Text] [Related]
9. Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis.
Lee CH; Vellayappan B; Tan CH
Br J Radiol; 2022 Mar; 95(1131):20210509. PubMed ID: 34520694
[TBL] [Abstract][Full Text] [Related]
10. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
[TBL] [Abstract][Full Text] [Related]
11. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.
Rosenkrantz AB; Lim RP; Haghighi M; Somberg MB; Babb JS; Taneja SS
AJR Am J Roentgenol; 2013 Oct; 201(4):W612-8. PubMed ID: 24059400
[TBL] [Abstract][Full Text] [Related]
12. Inter-reader agreement of the prostate imaging reporting and data system version v2.1 for detection of prostate cancer: A systematic review and meta-analysis.
Wen J; Ji Y; Han J; Shen X; Qiu Y
Front Oncol; 2022; 12():1013941. PubMed ID: 36248983
[TBL] [Abstract][Full Text] [Related]
13. Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
Zhang KS; Mayer P; Glemser PA; Tavakoli AA; Keymling M; Rotkopf LT; Meinzer C; Görtz M; Kauczor HU; Hielscher T; Stenzinger A; Bonekamp D; Hohenfellner M; Schlemmer HP
Eur J Radiol; 2023 Oct; 167():111026. PubMed ID: 37639843
[TBL] [Abstract][Full Text] [Related]
14. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.
Vargas HA; Hötker AM; Goldman DA; Moskowitz CS; Gondo T; Matsumoto K; Ehdaie B; Woo S; Fine SW; Reuter VE; Sala E; Hricak H
Eur Radiol; 2016 Jun; 26(6):1606-12. PubMed ID: 26396111
[TBL] [Abstract][Full Text] [Related]
15. Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI.
Brizmohun Appayya M; Sidhu HS; Dikaios N; Johnston EW; Simmons LA; Freeman A; Kirkham AP; Ahmed HU; Punwani S
Br J Radiol; 2018 Feb; 91(1083):20170645. PubMed ID: 29189042
[TBL] [Abstract][Full Text] [Related]
16. Interobserver Agreement and Positivity of PI-RADS Version 2 Among Radiologists with Different Levels of Experience.
Mussi TC; Yamauchi FI; Tridente CF; Tachibana A; Tonso VM; Recchimuzzi DR; de Souza Leão LR; Luz DC; Martins T; Baroni RH
Acad Radiol; 2019 Aug; 26(8):1017-1022. PubMed ID: 30268722
[TBL] [Abstract][Full Text] [Related]
17. Comparison of prostate imaging reporting and data system v2.1 and 2 in transition and peripheral zones: evaluation of interreader agreement and diagnostic performance in detecting clinically significant prostate cancer.
Urase Y; Ueno Y; Tamada T; Sofue K; Takahashi S; Hinata N; Harada K; Fujisawa M; Murakami T
Br J Radiol; 2022 Mar; 95(1131):20201434. PubMed ID: 33882243
[TBL] [Abstract][Full Text] [Related]
18. How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1.
Linhares Moreira AS; De Visschere P; Van Praet C; Villeirs G
Acta Radiol; 2021 Jun; 62(6):839-847. PubMed ID: 32702998
[TBL] [Abstract][Full Text] [Related]
19. Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.
Rosenkrantz AB; Babb JS; Taneja SS; Ream JM
Radiology; 2017 Apr; 283(1):119-129. PubMed ID: 27783538
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and grade of malignancy differences with respect to the area of involvement in multiparametric resonance imaging of the prostate in the diagnosis of prostate cancer using the PI-RADS version 2 classification.
Rodríguez-Cabello MA; Méndez-Rubio S; Sanz-Miguelañez JL; Moraga-Sanz A; Aulló-González C; Platas-Sancho A
World J Urol; 2023 Aug; 41(8):2155-2163. PubMed ID: 37326654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
